The clinical supply chain is one-of-a-kind. The chain from raw ingredients to global distribution to customers is referred to as the clinical supply chain (the patient). A clinical supply management system that handles all of the complexities of healthcare supplies is the heart of any good clinical supply chain system.
We will customize a service to meet all of your clinical trial supply needs while still reducing your logistical pressure. We may also provide a variety of specialized transport and storage services for cold chain goods, which are an important part of a safe and reliable clinical trial supply chain.
We recognize that in the supply chain for products involved with Clinical Trials, timing is crucial, and we will use our extensive experience and dedication to develop unique sourcing and supply solutions to meet your ‘first to file/market’ schedules.
Our seasoned Clinical Trial Supply procurement team can get products from all around the world and through a variety of regulated channels. We also have extensive experience with GMDP, which allows us to handle all parts of shipping in a validated and transparent manner, ensuring the integrity of your product from the place of origin to its final destination.
The entire clinical supply chain is managed holistically.
Expertise and practice from around the world and locally to handle the complexity of every form and scale of a clinical trial.
Material supply inventory and warehouse management scheme.
Determines marking needs and global mark text translation capabilities in-house.
Material supply inventory and warehouse management scheme.
On behalf of the sponsor, coordinates drug manufacture and distributes supplies to depots, stores, and trial locations.
Maintains supplies and keeps track of shipments.
Timely trial start-ups and inventory supply tracking at the site help accelerated patient registration and substantial cost savings.
A global depot network that is qualified and well-established.
Material supply inventory and warehouse management scheme.
Procedures for return and destruction that are standardized.
BIOSIMILARS
In terms of quality, safety, and efficacy, biosimilars have been found to have no clinically relevant variations from the originator's licensed biological drug.
COMPARATOR DRUG
To conduct comparative trials, contract research organizations (CROs) must have solid procedures for sourcing and delivering the medicine to all trial sites on a consistent basis.
REFERENCE LISTED DRUG
We recognize that bio-analytical/equivalence investigations take time, effort, and planning. Allow our group of expert team members to assist you in locating and supplying RLDs.
